Artículos por temáticas

Subjective memory decline in Parkinson's disease patients with and without fatigue

Siciliano M, Trojano L, De Micco R, Russo A, Tedeschi G, Tessitore A.

Parkinsonism Relat Disord. 2020 Jan;70:15-19. doi: 10.1016/j.parkreldis.2019.11.017. Epub 2019 Nov 21.

The efficacy of the Strength, Hope and Resourcefulness Program for people with Parkinson's disease (SHARP-PWP): A mixed methods study

Murdoch KC, Larsen D, Edey W, Arsenault C, Howell A, Joyce A, Sandham T, Miyasaki JM.

Parkinsonism Relat Disord. 2020 Jan;70:7-12. doi: 10.1016/j.parkreldis.2019.11.010. Epub 2019 Nov 16.

Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications

Angelopoulou E, Pyrgelis ES, Piperi C.

Neurochem Int. 2020 Jan;132:104612. doi: 10.1016/j.neuint.2019.104612. Epub 2019 Nov 27.

Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease

Morales-Briceño H, Fung VSC.

Mov Disord. 2020 Jan;35(1):81. doi: 10.1002/mds.27934. Epub 2019 Nov 29.

Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson's disease

Oliveira LOD, da Silva PIC, Filho RPR, Progênio RCS, de Oliveira VDPS, Silva RC, de Andrade MC, da Silva Freitas JJ, Kietzer KS.

Metab Brain Dis. 2020 Jan;35(1):175-181. doi: 10.1007/s11011-019-00507-z. Epub 2019 Nov 28.

Dissecting beta-state changes during timed movement preparation in Parkinson's disease

Heideman SG, Quinn AJ, Woolrich MW, van Ede F, Nobre AC.

Prog Neurobiol. 2020 Jan;184:101731. doi: 10.1016/j.pneurobio.2019.101731. Epub 2019 Nov 25.

Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease

Parkhe A, Parekh P, Nalla LV, Sharma N, Sharma M, Gadepalli A, Kate A, Khairnar A.

Neurosci Lett. 2020 Jan 18;716:134652. doi: 10.1016/j.neulet.2019.134652. Epub 2019 Nov 25.

Altered Granger causality connectivity within motor-related regions of patients with Parkinson's disease: a resting-state fMRI study

Hao L, Sheng Z, Ruijun W, Kun HZ, Peng Z, Yu H.

Neuroradiology. 2020 Jan;62(1):63-69. doi: 10.1007/s00234-019-02311-z. Epub 2019 Nov 26.

Is Parkinson's Disease a Very Rare Pathology in Centenarians? A Clinical Study in a Cohort of Subjects

Marcon G, Manganotti P, Tettamanti M.

J Alzheimers Dis. 2020;73(1):73-76. doi: 10.3233/JAD-190717.

Postural impairments in Parkinson's disease are not associated with changes in circadian rhythms changes

Zulai LC, Albuquerque AM, Papcke C, Louzada FM, Scheeren EM.

Chronobiol Int. 2020 Jan;37(1):135-141. doi: 10.1080/07420528.2019.1692350. Epub 2019 Nov 25.

Gold-nanourchin seeded single-walled carbon nanotube on voltammetry sensor for diagnosing neurogenerative Parkinson's disease

Zhang R, Wang S, Huang X, Yang Y, Fan H, Yang F, Li J, Dong X, Feng S, Anbu P, Gopinath SCB, Xin T.

Anal Chim Acta. 2020 Jan 15;1094:142-150. doi: 10.1016/j.aca.2019.10.012. Epub 2019 Oct 12.

Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson's disease

Feng ST, Wang ZZ, Yuan YH, Wang XL, Sun HM, Chen NH, Zhang Y.

Pharmacol Res. 2020 Jan;151:104553. doi: 10.1016/j.phrs.2019.104553. Epub 2019 Nov 21.

The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry

Li SJ, Ren YD, Li J, Cao B, Ma C, Qin SS, Li XR.

Life Sci. 2020 Jan 1;240:117091. doi: 10.1016/j.lfs.2019.117091. Epub 2019 Nov 21.

Nuclear accumulation of GAPDH, GluA2 and p53 in post-mortem substantia nigral region of patients with Parkinson's disease

Sekar S, Taghibiglou C.

Neurosci Lett. 2020 Jan 18;716:134641. doi: 10.1016/j.neulet.2019.134641. Epub 2019 Nov 20.

Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia

Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, Leonard HL, Grenn FP,

Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350.